Bosnia and Herzegovina vs Congo: Proportion of the target population who received 3 doses of
Bosnia and Herzegovina
79.0%
in 2024
Congo
78.0%
in 2024
Bosnia and Herzegovina rank
159th
Congo rank
161st
Proportion of the target population who received 3 doses of over time
- Bosnia and Herzegovina
- Congo
How they compare
Bosnia and Herzegovina currently reports 79.0% against 78.0% in Congo, a difference of 1.0%.
The two have swapped places 6 times across 25 shared years of data; in 2000 it was Bosnia and Herzegovina ahead.
Bosnia and Herzegovina ranks 159th and Congo ranks 161st of 209 countries.
Across the 3 decades both report, Bosnia and Herzegovina averaged higher in 2 and Congo in 1.
Head to head by decade
| Decade | Bosnia and Herzegovina | Congo | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 88.3% | 59.2% | 29.1% | Bosnia and Herzegovina |
| 2010s | 83.2% | 79.3% | 3.9% | Bosnia and Herzegovina |
| 2020s | 76.2% | 76.8% | 0.6% | Congo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received 3 doses of, Bosnia and Herzegovina or Congo?
- Bosnia and Herzegovina, at 79.0% against 78.0% in Congo as of 2024.
- What is the difference in proportion of the target population who received 3 doses of between Bosnia and Herzegovina and Congo?
- 1.0%, with Bosnia and Herzegovina ahead.
- How many years of comparable data are there for Bosnia and Herzegovina and Congo?
- 25 years are reported by both, from 2000 to 2024.
- How do Bosnia and Herzegovina and Congo rank globally for proportion of the target population who received 3 doses of?
- Bosnia and Herzegovina ranks 159th and Congo ranks 161st of 209 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received 3 doses of diphtheria-tetanus-pertussis (DTP3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.